ANTONIO
OSUNA ORTEGA
COLABORADOR EXTRAORDINARIO
Hospital del Mar
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital del Mar (4)
2022
-
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study
Clinical transplantation, Vol. 36, Núm. 3, pp. e14550
2019
-
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study
Transplantation, Vol. 103, Núm. 9, pp. 1953-1963
2018
-
Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial
American Journal of Transplantation, Vol. 18, Núm. 4, pp. 927-935
2009
-
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32